Occult Gynecologic Cancer in Women Undergoing Hysterectomy or Myomectomy for Benign Indications
- PMID: 29528920
- DOI: 10.1097/AOG.0000000000002521
Occult Gynecologic Cancer in Women Undergoing Hysterectomy or Myomectomy for Benign Indications
Abstract
Objective: To estimate the prevalence of corpus uteri, cervix uteri, and ovarian malignancy in women undergoing hysterectomy or myomectomy for presumed benign indications.
Methods: We conducted a secondary analysis of data from the 2014-2015 American College of Surgeons National Surgical Quality Improvement Program. Adult women undergoing hysterectomies and myomectomies without evidence for known or suspected cancer at the beginning of surgery were identified from the database. Our primary outcome measure was pathology-confirmed malignancy in the corpus uteri, cervix uteri, and ovary. We performed adjusted logistic regression analysis to examine the association of patient characteristics with the risk for malignancy.
Results: Our sample included 24,076 women undergoing hysterectomy and 2,368 women undergoing myomectomy. Malignancy of the corpus uteri was found in 1.44% (95% CI 1.29-1.59%) of the women undergoing hysterectomy. The prevalence varied considerably across surgical routes with the rate being 0.23% (95% CI 0.06-0.58%) in laparoscopic supracervical hysterectomy and 1.89% (95% CI 1.65-2.14%) in total laparoscopic or laparoscopic-assisted vaginal hysterectomy. Older women were significantly more likely to have preoperatively undetected malignancy of the corpus uteri (adjusted odds ratio 6.46, 95% CI 4.96-8.41 for age 55 years or older vs age 40-54 years). Additionally, 0.60% (95% CI 0.50-0.70%) and 0.19% (95% CI 0.14-0.25%) of the women undergoing hysterectomy were found to have malignancy of the cervix uteri and the ovary, respectively. Among patients undergoing myomectomy, 0.21% (95% CI 0.03-0.40%) were found to have malignancy of the corpus uteri with no occult cervical or ovarian cancer identified.
Conclusion: Prevalence of occult corpus uteri, cervical, and ovarian malignancy was 1.44%, 0.60%, and 0.19%, respectively, among women undergoing hysterectomy and it varied by patient age and surgical route.
Comment in
-
Occult Gynecologic Cancer in Women Undergoing Hysterectomy or Myomectomy for Benign Indications.Obstet Gynecol. 2018 Aug;132(2):518-519. doi: 10.1097/AOG.0000000000002710. Obstet Gynecol. 2018. PMID: 30045196 No abstract available.
-
Occult Gynecologic Cancer in Women Undergoing Hysterectomy or Myomectomy for Benign Indications.Obstet Gynecol. 2018 Aug;132(2):519. doi: 10.1097/AOG.0000000000002769. Obstet Gynecol. 2018. PMID: 30045197 No abstract available.
-
In Reply.Obstet Gynecol. 2018 Aug;132(2):519-520. doi: 10.1097/AOG.0000000000002770. Obstet Gynecol. 2018. PMID: 30045198 No abstract available.
Similar articles
-
Uterine weight and complications after abdominal, laparoscopic, and vaginal hysterectomy.Am J Obstet Gynecol. 2018 Nov;219(5):480.e1-480.e8. doi: 10.1016/j.ajog.2018.06.015. Epub 2018 Jun 28. Am J Obstet Gynecol. 2018. PMID: 29959931
-
Prevalence of undiagnosed uterine leiomyosarcoma in women undergoing hysterectomy or myomectomy for benign indications.Eur J Obstet Gynecol Reprod Biol. 2017 Sep;216:239-244. doi: 10.1016/j.ejogrb.2017.06.029. Epub 2017 Jun 21. Eur J Obstet Gynecol Reprod Biol. 2017. PMID: 28743407
-
Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation.Womens Health Issues. 2016 Jan-Feb;26(1):21-6. doi: 10.1016/j.whi.2015.09.008. Epub 2015 Nov 19. Womens Health Issues. 2016. PMID: 26701205
-
Minimally invasive surgical techniques versus open myomectomy for uterine fibroids.Cochrane Database Syst Rev. 2014 Oct 21;(10):CD004638. doi: 10.1002/14651858.CD004638.pub3. Cochrane Database Syst Rev. 2014. PMID: 25331441 Review.
-
Electric morcellation-related reoperations after laparoscopic myomectomy and nonmyomectomy procedures.J Minim Invasive Gynecol. 2015 Feb;22(2):163-76. doi: 10.1016/j.jmig.2014.09.006. Epub 2014 Sep 11. J Minim Invasive Gynecol. 2015. PMID: 25218993 Review.
Cited by 4 articles
-
Port site recurrence, an unintended consequence of laparoscopic resection of ovarian cancer. A case report.Int J Surg Case Rep. 2019;62:5-8. doi: 10.1016/j.ijscr.2019.07.024. Epub 2019 Jul 19. Int J Surg Case Rep. 2019. PMID: 31401352 Free PMC article.
-
Surgical Care for Women with Endometrial Cancer in Florida.J Gynecol Surg. 2019 Jun 1;35(3):163-171. doi: 10.1089/gyn.2018.0086. Epub 2019 May 29. J Gynecol Surg. 2019. PMID: 31289427 Free PMC article.
-
An occult urothelial carcinoma with wide multiorgan metastases and its genetic alteration profiling: Case report and literature review.Medicine (Baltimore). 2019 Apr;98(16):e15245. doi: 10.1097/MD.0000000000015245. Medicine (Baltimore). 2019. PMID: 31008958 Free PMC article. Review.
-
Prevalence, characteristics, and risk factors of occult uterine cancer in presumed benign hysterectomy.Am J Obstet Gynecol. 2019 Jul;221(1):39.e1-39.e14. doi: 10.1016/j.ajog.2019.02.051. Epub 2019 Mar 7. Am J Obstet Gynecol. 2019. PMID: 30853364 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
